methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

C49H56N8O8 — CID 123532898

IUPACmethyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
SMILESCOCC1CC(c2nc3c(ccc4cc5c(cc43)OCc3cc(-c4ccc6nc(C7CCCN7C(=O)C(NC(=O)OC)C(C)C)[nH]c6c4)ccc3-5)[nH]2)N(C(=O)C(NC(=O)OC)C(C)C)C1
InChIInChI=1S/C49H56N8O8/c1-25(2)41(54-48(60)63-6)46(58)56-16-8-9-38(56)44-50-35-14-11-29(20-37(35)52-44)28-10-13-32-31(18-28)24-65-40-21-33-30(19-34(32)40)12-15-36-43(33)53-45(51-36)39-17-27(23-62-5)22-57(39)47(59)42(26(3)4)55-49(61)64-7/h10-15,18-21,25-27,38-39,41-42H,8-9,16-17,22-24H2,1-7H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)
InChIKeyVAISEJSSSONEOO-UHFFFAOYSA-N
MW885.04 g/mol
LogP7.78
Rot. Bonds11

About methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 123532898) has the molecular formula C49H56N8O8 and a molecular weight of 885.04 g/mol. Its IUPAC name is methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.

Molecular Properties

Compound Namemethyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
PubChem CID123532898
Molecular FormulaC49H56N8O8
Molecular Weight885.04 g/mol
Exact Mass884.42
IUPAC Namemethyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
SMILESCOCC1CC(c2nc3c(ccc4cc5c(cc43)OCc3cc(-c4ccc6nc(C7CCCN7C(=O)C(NC(=O)OC)C(C)C)[nH]c6c4)ccc3-5)[nH]2)N(C(=O)C(NC(=O)OC)C(C)C)C1
InChIInChI=1S/C49H56N8O8/c1-25(2)41(54-48(60)63-6)46(58)56-16-8-9-38(56)44-50-35-14-11-29(20-37(35)52-44)28-10-13-32-31(18-28)24-65-40-21-33-30(19-34(32)40)12-15-36-43(33)53-45(51-36)39-17-27(23-62-5)22-57(39)47(59)42(26(3)4)55-49(61)64-7/h10-15,18-21,25-27,38-39,41-42H,8-9,16-17,22-24H2,1-7H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)
InChIKeyVAISEJSSSONEOO-UHFFFAOYSA-N
XLogP7.78
TPSA193.10 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds11
Heavy Atoms65
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500885.04
LogP ≤ 57.78
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Analyze methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
The IUPAC name of methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (CID 123532898) is methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
What is the SMILES notation for methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
The canonical SMILES for methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate is COCC1CC(c2nc3c(ccc4cc5c(cc43)OCc3cc(-c4ccc6nc(C7CCCN7C(=O)C(NC(=O)OC)C(C)C)[nH]c6c4)ccc3-5)[nH]2)N(C(=O)C(NC(=O)OC)C(C)C)C1.
What is the InChIKey of methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
The InChIKey is VAISEJSSSONEOO-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H56N8O8/c1-25(2)41(54-48(60)63-6)46(58)56-16-8-9-38(56)44-50-35-14-11-29(20-37(35)52-44)28-10-13-32-31(18-28)24-65-40-21-33-30(19-34(32)40)12-15-36-43(33)53-45(51-36)39-17-27(23-62-5)22-57(39)47(59)42(26(3)4)55-49(61)64-7/h10-15,18-21,25-27,38-39,41-42H,8-9,16-17,22-24H2,1-7H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61).
What are the key properties of methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate has a molecular weight of 885.04 g/mol, XLogP of 7.78, 11 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[1-[2-[6-[6-[1-[2-(methoxycarbonylamino)-3-methylbutanoyl]-4-(methoxymethyl)pyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate is sourced from PubChem (CID 123532898), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).